GlobeNewswire•December 6, 2019 VANCOUVER, British Columbia, Dec. 06, 2019 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) (TSXV: WML; OTCQX: WMLLF; SSE: WMLCL; Frankfurt: EJZN) announces it will be presenting at the 12th annual LD Micro Main Event on Tuesday, December 10 at 3:00PM PST / 6:00PM EST. Tim McCutcheon, President of Wealth…
DetailsGlobeNewswire•December 5, 2019 CURE CEO to discuss company’s expanded technology platform and pharmaceutical pipeline LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD Micro Main Event on Wednesday, December 11 at 9:45 AM PST/…
DetailsIndustry veteran brings 40 year of experience to support CURE’s rapid growth OXNARD, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it has named John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience…
DetailsGlobeNewswire•November 14, 2019 OXNARD, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR) (“CURE”), an innovative drug delivery and development company, today announced that it purchased a $200,000 convertible promissory note issued by Coeptis Pharmaceuticals, Inc., a biopharmaceutical company engaged in the acquisition, development and commercialization of branded 505(b)(2) pharmaceutical products. This note represents…
DetailsGlobeNewswireNovember 12, 2019 Closes Flow-Through Financing VANCOUVER, British Columbia, Nov. 12, 2019 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQX: WMLLF; SSE: WMLCL; Frankfurt: EJZN), provides a corporate update the status of its assets and the Company’s corporate development, as well as announces the closing of its recently announced…
DetailsGlobeNewswire•October 30, 2019 VANCOUVER, British Columbia, Oct. 30, 2019 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQX: WMLLF; SSE: WMLCL; Frankfurt: EJZN), reports it has successfully negotiated surface access rights to the Valsequillo Silver project (“Valsequillo” or the “Property”) located in southern Chihuahua state, Mexico (Figure 1). The Company…
DetailsGlobeNewswire•October 15, 2019 VANCOUVER, British Columbia, Oct. 15, 2019 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQX: WMLLF; SSE: WMLCL; Frankfurt: EJZN), is pleased to announce it has signed a strategic memorandum of understanding (the “MOU”) with Uranium One Group (“U1G”). The MOU provides for the acquisition (the “Proposed…
DetailsGlobeNewswire•October 9, 2019 Alternative dosage demand drives company’s manufacturing expansion OXNARD, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, announces the expansion of its oral drug delivery product line creating CUREform™ which includes CUREfilm®, one of the most advanced oral thin films on the market today.…
Details